https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
10-2.73) and admission to hospital (HR 4.00, 95% CI 1.83-8.7 were identified as independent mortality risk factors in the elderly haemodialysis population. Treatment with glucocorticoids reduced the risk of death (HR 0.68, 95% CI 0.48-0.96). In conclusion, mortality is dramatically increased in elderly haemodialysis patients with COVID-19. Our results suggest that this high risk population should be prioritized in terms of protection and vaccination.The Swiss Ablation Registry provides a national database for electrophysi
Like
Comment
Share
